EU MDR and IVDR: Key Updates and Compliance Strategies
Watch the Course Now
Watch the Course Now
About the Course
EU MDR and IVDR requirements continue to shift as manufacturers manage extended transition periods, updated guidance documents, notified body capacity constraints, and expanding post-market obligations. Organizations marketing medical devices and in vitro diagnostics in the European Union must maintain current regulatory knowledge while addressing evolving expectations for clinical evidence, device traceability, vigilance reporting, and certification readiness. Delays in adapting compliance processes can affect submissions, product continuity, and regulatory timelines across multiple product categories and certification activities.
Current MDR and IVDR developments place additional attention on EUDAMED reporting responsibilities, UDI implementation, performance evaluation requirements, and ongoing post-market surveillance activities. Regulatory teams must also prepare for changing interpretations issued through European Commission and MDCG updates while managing technical documentation and audit preparation. This course provides focused regulatory context and practical compliance considerations relevant to 2025 deadlines, legacy device transitions, and day-to-day operational decision-making.
Key Areas Covered
Quality training, expert insights, and answers that matter. Know your Expert
Ready to Strengthen Your Team? Let’s Build Your Training Plan.
Your team deserves the clarity.
Your organization deserves the confidence.
Upcoming Courses
Your TalkFDA Webinar Experience
1. Confirmation
3. Access course materials
4. Watch The Streaming and Complete your Course


